日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Fast Real-Time Assessment of Combination Therapies in Immuno-ONcology in patients with advanced non-small-cell lung cancer (FRACTION-Lung)

快速实时评估免疫肿瘤学联合疗法在晚期非小细胞肺癌患者中的应用(FRACTION-Lung)

He, K; Forde, P M; Govindan, R; Santoro, A; Gettinger, S; Borghaei, H; Spira, A; Chu, Q; Zinner, R; Schoenfeld, A J; Camidge, D R; Spigel, D R; Gurpide, A; Juergens, R A; Laurie, S A; Cerra, M; Spires, T; Greenawalt, D M; Rapoport, I; Gainor, J F

Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients

血清白细胞介素-8 (IL-8) 水平的变化反映并预测黑色素瘤和非小细胞肺癌患者对PD-1抑制剂治疗的反应。

Sanmamed, M F; Perez-Gracia, J L; Schalper, K A; Fusco, J P; Gonzalez, A; Rodriguez-Ruiz, M E; Oñate, C; Perez, G; Alfaro, C; Martín-Algarra, S; Andueza, M P; Gurpide, A; Morgado, M; Wang, J; Bacchiocchi, A; Halaban, R; Kluger, H; Chen, L; Sznol, M; Melero, I

Identification of TNF-alpha and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array

利用人细胞因子芯片鉴定TNF-α和MMP-9作为肾细胞癌患者舒尼替尼疗效的潜在基线预测血清标志物

Perez-Gracia, J L; Prior, C; Guillén-Grima, F; Segura, V; Gonzalez, A; Panizo, A; Melero, I; Grande-Pulido, E; Gurpide, A; Gil-Bazo, I; Calvo, A

Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes.

贝伐珠单抗、舒尼替尼和索拉非尼作为单一药物或联合用药对 VEGF 抑制人类单核细胞分化为树突状细胞的影响

Alfaro C, Suarez N, Gonzalez A, Solano S, Erro L, Dubrot J, Palazon A, Hervas-Stubbs S, Gurpide A, Lopez-Picazo J M, Grande-Pulido E, Melero I, Perez-Gracia J L